Lazard Asset Management Portfolio holdings
AUM
$72.7B
1-Year Return
14.89%
This Quarter Return
+6.46%
1 Year Return
+14.89%
3 Year Return
+61.14%
5 Year Return
+112.7%
10 Year Return
+262.42%
AUM
$81.2B
AUM Growth
+$4.94B
(+6.5%)
Cap. Flow
-$6.9B
Cap. Flow
% of AUM
-8.49%
Top 10 Holdings %
Top 10 Hldgs %
23.23%
Holding
2,664
New
307
Increased
787
Reduced
648
Closed
292
Top Buys
| 1 |
Exelon
EXC
|
+$404M |
| 2 |
American Electric Power
AEP
|
+$295M |
| 3 |
Johnson & Johnson
JNJ
|
+$241M |
| 4 |
UnitedHealth
UNH
|
+$235M |
| 5 |
Charles Schwab
SCHW
|
+$232M |
Top Sells
| 1 |
Consolidated Edison
ED
|
+$312M |
| 2 |
PNC Financial Services
PNC
|
+$292M |
| 3 |
Dollar General
DG
|
+$283M |
| 4 |
Fiserv
FI
|
+$185M |
| 5 |
Salesforce
CRM
|
+$179M |
Sector Composition
| 1 | Technology | 19.56% |
| 2 | Healthcare | 13.87% |
| 3 | Financials | 13.29% |
| 4 | Industrials | 12.02% |
| 5 | Consumer Discretionary | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Cartesian Therapeutics
RNAC
$260M
| $12K | ﹤0.01% |
373
+8
| +2% | +$257 |
|
1952
Banco Santander
SAN
$148B
| $12K | ﹤0.01% |
3,291
+348
| +12% | +$1.27K |
|
|
EBTC
1953
DELISTED
Enterprise Bancorp
EBTC
| $11K | ﹤0.01% |
381
| – | – |
|
1954
Lineage Cell Therapeutics
LCTX
$283M
| $11K | ﹤0.01% |
8,380
+314
| +4% | +$412 |
|
1955
Solid Biosciences
SLDB
$409M
| $11K | ﹤0.01% |
2,216
+127
| +6% | +$630 |
|
1956
VSE Corp
VSEC
$3.39B
| $11K | ﹤0.01% |
209
-2,056
| -91% | -$108K |
|
1957
Xperi
XPER
$275M
| $11K | ﹤0.01% |
853
| – | – |
|
1958
Atara Biotherapeutics
ATRA
$82.5M
| $10K | ﹤0.01% |
271
+99
| +58% | +$3.65K |
|
1959
BHP
BHP
$135B
| $10K | ﹤0.01% |
168
+44
| +35% | +$2.62K |
|
1960
Conagra Brands
CAG
$9.26B
| $10K | ﹤0.01% |
325
-33
| -9% | -$1.02K |
|
|
DRD
1961
DRDGold
DRD
$1.97B
| $10K | ﹤0.01% |
+996
| New | +$10K |
|
1962
Tango Therapeutics
TNGX
$702M
| $10K | ﹤0.01% |
3,341
+97
| +3% | +$290 |
|
|
GRTS
1963
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $10K | ﹤0.01% |
5,631
+149
| +3% | +$265 |
|
1964
Barclays
BCS
$71.8B
| $9K | ﹤0.01% |
1,204
-1,097
| -48% | -$8.2K |
|
1965
CorVel
CRVL
$4.48B
| $9K | ﹤0.01% |
147
-1,050
| -88% | -$64.3K |
|
1966
DT Midstream
DTM
$10.8B
| $9K | ﹤0.01% |
185
| – | – |
|
1967
CGI
GIB
$20.7B
| $9K | ﹤0.01% |
+88
| New | +$9K |
|
1968
ProQR Therapeutics
PRQR
$232M
| $9K | ﹤0.01% |
5,912
+155
| +3% | +$236 |
|
|
OMGA
1969
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $9K | ﹤0.01% |
1,714
+72
| +4% | +$378 |
|
|
CHUY
1970
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $9K | ﹤0.01% |
228
-1,420
| -86% | -$56.1K |
|
|
AFMD
1971
DELISTED
Affimed
AFMD
| $8K | ﹤0.01% |
1,427
+9
| +0.6% | +$50 |
|
1972
Repligen
RGEN
$6.76B
| $8K | ﹤0.01% |
65
-430
| -87% | -$52.9K |
|
1973
Rentokil
RTO
$12.8B
| $8K | ﹤0.01% |
212
| – | – |
|
1974
ArcelorMittal
MT
$26.1B
| $7K | ﹤0.01% |
280
| – | – |
|
1975
Patrick Industries
PATK
$3.7B
| $7K | ﹤0.01% |
146
-4,219
| -97% | -$202K |
|